Edition:
United States

Insider Trading: aTyr Pharma Inc (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

3.60USD
9 Dec 2016
Change (% chg)

$0.05 (+1.41%)
Prev Close
$3.55
Open
$3.55
Day's High
$3.65
Day's Low
$3.53
Volume
18,260
Avg. Vol
23,087
52-wk High
$10.93
52-wk Low
$2.48

LORIMIER BRADLEY G

Institutional Holders

% Shares Owned: 75.43%
# of Holders: 55
Total Shares Held: 17,891,644
3 Mo. Net Change: 385,849
# New Positions: 8
# Closed Positions: 16
# Increased Positions: 25
# Reduced Positions: 26
# Net Buyers: -1

Officers & Directors

Name Age Since Current Position

John Mendlein

56 2011 Chief Executive Officer and Executive Chairman, Board of Directors

John Clarke

62 2005 Non-Executive Independent Chairman of the Board

John Blake

39 2016 Principal Financial Officer, Chief Accounting Officer

David King

2016 Senior Vice President - Research

Melissa Ashlock

57 2011 Vice President - External Scientific Alliances and Human Genetics

Holly Chrzanowski

49 2013 Vice President - Enterprise Talent and Organization

Andrew Cubitt

52 2011 Vice President - Product Protection

John McKew

51 2014 Vice President - Research

Fred Ramsdell

54 2014 Vice President - Immunology

Sanuj Ravindran

2016 Chief Business Officer

Sanjay Shukla

2016 Chief Medical Officer

Srinivas Akkaraju

48 2015 Non-Executive Independent Director

James Blair

75 2010 Non-Executive Independent Director

Kathryn Falberg

55 2014 Non-Executive Independent Director

Mark Goldberg

61 2015 Non-Executive Independent Director

Amir Nashat

37 2006 Non-Executive Independent Director

Paul Schimmel

75 2005 Non-Executive Independent Director